Description
Trastuzumab, marketed under the brand name HERTRAZ 440, It is an prescription medication that has been approved in 1998 to treat HER2+ metastatic breast cancer. In 2006, the FDA approved Herceptin to treat HER2+ early breast cancer.
What is HERTRAZ 440 (Trastuzumab) ?
Hertraz is indicated for the treatment of metastatic breast cancer patients who have human epidermal growth factor receptor 2 (HER2)-overexpressing tumours. Early Breast Cancer (EBC) Hertraz is indicated for the treatment of adult patients with HER2-positive early breast cancer.
How to order approved “HERTRAZ 440 (Trastuzumab) for Injection” Medicine?
HERTRAZ 440 (Trastuzumab) is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing HERTRAZ 440 and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.





